Plum, Patrick Sven http://orcid.org/0000-0002-8165-4553
Ulase, Dita
Bollschweiler, Elfriede
Chon, Seung-Hun
Berlth, Felix
Zander, Thomas
Alakus, Hakan
Hölscher, Arnulf H.
Bruns, Christiane J.
Schallenberg, Simon
Quaas, Alexander
Loeser, Heike
Article History
Received: 7 June 2018
Accepted: 28 June 2018
First Online: 4 July 2018
Compliance with ethical standards
:
: Dr. Zander reports grants from NRW Government during the conduct of the study; personal fees from Roche, personal fees from Novartis, personal fees from Lilly, personal fees from MSD, personal fees from BMS, personal fees from AstraZeneca, personal fees from Sanofi, outside the submitted work. All other authors declare that they have no conflict of interest.
: All procedures performed in the current study involving human tumor specimens were in accordance with ethical standards of the local research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of the University Hospital of Cologne.
: The single protein immunohistochemical staining was performed during the regular pathological diagnostics and therefore no additional informed consent was obtained.